首页> 外文学位 >Part I. Isodityrosine-derived cyclic peptides: Total syntheses of L,L-isodityrosine, K-13, and OF4949-III and OF4949-IV. Part II. Total syntheses of deoxybouvardin and RA-VII and design, syntheses, and evaluation of structural analogs.
【24h】

Part I. Isodityrosine-derived cyclic peptides: Total syntheses of L,L-isodityrosine, K-13, and OF4949-III and OF4949-IV. Part II. Total syntheses of deoxybouvardin and RA-VII and design, syntheses, and evaluation of structural analogs.

机译:第一部分:异麦芽氨酸衍生的环肽:L,L-异麦芽碱,K-13和OF4949-III和OF4949-IV的总合成。第二部分脱氧布瓦丁和RA-VII的总合成以及结构类似物的设计,合成和评估。

获取原文
获取原文并翻译 | 示例

摘要

The glycoprotein characteristic of plant cell walls undergoing extensin growth has been shown to contain the crosslinking amino acid isodityrosine. The structure of isodityrosine is an amino acid dimer in which two tyrosine units are linked through an unsymmetrical diphenyl ether bond. Additional efforts have established the natural occurrence of the antifungal agent piperazinomycin, the aminopeptidase B inhibitors OF4949-I - IV, the angiotensin converting enzyme (ACE) inhibitor K-13, and a class of bicyclic hexapeptide antitumor antibiotics including bouvardin and deoxybouvardin and RA-I - RA-IV bearing structural subunits derived from isodityrosine. The isodityrosine-derived unit present in the agents has proven to be fundamentally important to their properties. The isodityrosine-derived 14-membered segment of bouvardin/deoxybouvardin has been suggested to be responsible for the attainment and/or maintenance of an otherwise inaccessible, active conformation of the parent cyclic hexapeptides. Herein the development of reaction conditions for implementation of an activated Ullmann diaryl ether condensation reaction that may be conducted without amino acid racemization and that has proven suitable for incorporation of the selectively-protected catechol of functionalized scL-Dopa derivatives is described. The application of this procedure in the total syntheses of scL, scL-isodityrosine, K-13, and OF4949-III/OF4949-IV is detailed. A study of the macrolactam cyclization reaction required for formation of the 17-membered tripeptides incorporating a diaryl ether linked meta- and paracyclophane structural subunit is provided. Structural features of K-13 that contribute to its angiotensin converting enzyme inhibitory activity are defined and OF4949 structural features that contribute to aminopeptidase B inhibitory activity are detailed. The demonstration and definition of the scope of an intramolecular Ullmann condensation reaction suitable for the use in macrocyclization reactions leading to 14-membered para- and metacyclophanes possessing a diaryl ether are detailed. A concise synthesis of RA-VII and deoxybouvardin is detailed and is based on the implementation of an intramolecular Ullmann reaction as the key macrocyclization process for the preparation of the 14-membered isodityrosine-derived 14-membered cyclophane unit of the bicyclic hexapeptides. The design, synthesis, and evaluation of structural and conformational analogs of bouvardin/deoxybouvardin are presented.
机译:已经显示出经历延伸蛋白生长的植物细胞壁的糖蛋白特征是含有交联氨基酸异三酪氨酸。异酪氨酸的结构是氨基酸二聚体,其中两个酪氨酸单元通过不对称的二苯醚键连接。进一步的努力确定了抗真菌药哌嗪霉素,氨基肽酶B抑制剂OF4949-1-IV,血管紧张素转化酶(ACE)抑制剂K-13和一类双环六肽抗肿瘤抗生素(包括Bouvardin和Deoxybouvardin和RA- I-带有RA-IV的结构亚基,衍生自异碘酪氨酸。事实证明,试剂中存在的异硫代酪氨酸衍生单元对其性能至关重要。有人建议将bouvardin / deoxybouvardin的异碘酪氨酸衍生的14元片段负责和/或维持亲本环状六肽原本无法获得的活性构象。本文描述了用于实施活化的Ullmann二芳基醚缩合反应的反应条件的开发,该反应条件可在没有氨基酸外消旋的情况下进行,并且已证明适用于掺入官能化的scL-Dopa衍生物的选择性保护的邻苯二酚。详细介绍了该方法在scL,scL-异二酪氨酸,K-13和OF4949-III / OF4949-IV的总合成中的应用。提供了对形成结合有二芳基醚连接的间环和对环亲环的结构亚基的17元三肽所需的大内酰胺环化反应的研究。定义了有助于其血管紧张素转化酶抑制活性的K-13的结构特征,并详细描述了有助于氨肽酶B抑制活性的OF4949结构特征。分子内乌尔曼缩合反应的范围的证明和定义适用于大环化反应,该反应导致具有二芳基醚的14元对-和间-环戊烯。详细介绍了RA-VII和脱氧布瓦丁的简明合成方法,该方法基于分子内Ullmann反应的实施,该反应是制备双环六肽的14元异异酪氨酸衍生的14元环烷单元的关键大环化过程。介绍了bouvardin / deoxybouvardin的结构和构象类似物的设计,合成和评估。

著录项

  • 作者

    Yohannes, Daniel.;

  • 作者单位

    Purdue University.;

  • 授予单位 Purdue University.;
  • 学科 Chemistry Organic.;Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 1991
  • 页码 310 p.
  • 总页数 310
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:50:25

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号